MDY Mdy Healthcare

RNS Number:9201W
Medisys PLC
25 March 2004



For Immediate Release                                            25 March 2004


                                  Medisys PLC
                           ("Medisys" or "the Group")


      FirstOrder For NewTek Blood Glucose Monitor Received From Wal-Mart


Further to the AGM Statement released earlier today, Medisys announces that it
has now received the first purchase order for its NewTek product from Wal-Mart,
the Group's exclusive USretail partner for the product.


The purchase order was received overnight and will be fulfilled from existing
inventory.  It is anticipated that shipping will commence today.


Dave Conn, Chief Executive, commented: "The receipt of our first order from
Wal-Mart is a major milestone for the Group.  NewTek is the first ever fully
integrated, disposable blood glucose monitoring system offering a new level of
convenience to the user.  We are excited by its prospects as part of Wal-Mart's
well established ReliOn(R) brand, which offers value based products to their
diabetes customer."


                                    - Ends -

Enquiries:


Medisys PLC                                                  020 7563 5200
David Conn, Chief Executive Officer

Michael Barry, Chief Financial Officer

Weber Shandwick Square Mile                                  020 7067 0700
Kevin Smith/Susanne Walker

                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCVELBLZXBZBBB

MDY Healthcare (LSE:MDY)
Historical Stock Chart
Von Jun 2024 bis Jul 2024

MDY Healthcare (LSE:MDY)
Historical Stock Chart
Von Jul 2023 bis Jul 2024